Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported PRLD revenue for 2026-06-30 was $10.3M. Net income was -$24.3M. PRLD currently screens at market cap $346.5M.
Use this PRLD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PRLD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PRLD SEC filings page. Lician reads the product cache first so this HTML stays unique to Prelude Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PRLD income, balance, and cash tables.